Lexington, KY, United States
Gibson Laboratories LLC recalls
1 recall recorded since 2018, most recently on 20 January 2017. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)0
Terminated or completed1
Class I (FDA)0
Terminated Class II Medical devices
- Recall started
- 20 January 2017
- Terminated
- 20 February 2018
- Reason
- The firm information that the product was reporting false positive results
- Distribution
- Distributed to the states of AL, AZ & MS.
- Initiated
- Voluntary: Firm initiated
- Recall number
- Z-0606-2018
- Blastomyces dermatitidis Antiserum 1 mL vial GIBSON BIOSCIENCE. Catalog 200265 Intended for identification of the systemic fungal pathogens.
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.